Acrospire Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-9,898
| Closed | -$24K | – | 2079 |
|
|
2017
Q2 | $24K | Sell |
9,898
-27,332
| -73% | -$66.3K | 0.02% | 1433 |
|
|
2017
Q1 | $85K | Sell |
37,230
-92,250
| -71% | -$211K | 0.07% | 442 |
|
|
2016
Q4 | $274K | Buy |
129,480
+58,858
| +83% | +$125K | 0.11% | 182 |
|
|
2016
Q3 | $237K | Buy |
70,622
+5,281
| +8% | +$17.7K | 0.16% | 83 |
|
|
2016
Q2 | $205K | Sell |
65,341
-25,800
| -28% | -$80.9K | 0.15% | 64 |
|
|
2016
Q1 | $303K | Buy |
+91,141
| New | +$303K | 0.21% | 27 |
|